Your browser doesn't support javascript.
loading
IL-32 and its splice variants are associated with protection against Mycobacterium tuberculosis infection and skewing of Th1/Th17 cytokines.
Koeken, Valerie A C M; Verrall, Ayesha J; Ardiansyah, Edwin; Apriani, Lika; Dos Santos, Jéssica C; Kumar, Vinod; Alisjahbana, Bachti; Hill, Philip C; Joosten, Leo A B; van Crevel, Reinout; van Laarhoven, Arjan.
Afiliação
  • Koeken VACM; Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS), and Radboud Center of Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Verrall AJ; Department of Pathology and Molecular Medicine, University of Otago, Wellington, Wellington, New Zealand.
  • Ardiansyah E; Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS), and Radboud Center of Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Apriani L; Faculty of Medicine, TB-HIV Research Center, Universitas Padjadjaran, Bandung, Indonesia.
  • Dos Santos JC; Faculty of Medicine, TB-HIV Research Center, Universitas Padjadjaran, Bandung, Indonesia.
  • Kumar V; Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS), and Radboud Center of Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Alisjahbana B; Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS), and Radboud Center of Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Hill PC; Faculty of Medicine, TB-HIV Research Center, Universitas Padjadjaran, Bandung, Indonesia.
  • Joosten LAB; Department of Preventive and Social Medicine, Centre for International Health, University of Otago, Dunedin, New Zealand.
  • van Crevel R; Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS), and Radboud Center of Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Laarhoven A; Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS), and Radboud Center of Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.
J Leukoc Biol ; 107(1): 113-118, 2020 01.
Article em En | MEDLINE | ID: mdl-31378983
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Interleucinas / Processamento Alternativo / Células Th1 / Interleucina-17 / Células Th17 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Leukoc Biol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Interleucinas / Processamento Alternativo / Células Th1 / Interleucina-17 / Células Th17 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Leukoc Biol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda